A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Nov 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how an indoor air quality monitor can help create a smoke-free home for cancer patients who are part of the Tobacco Treatment Program at MSK. The goal is to see if having this device in their home can encourage patients and their families to reduce or quit smoking. The study is currently recruiting participants who are 18 years or older, smoke tobacco products, and live with at least one household member who also smokes. Participants need to be able to speak English and have Wi-Fi at home.
If you or a loved one qualify for this trial, you can expect to use the air quality monitor in your home and receive support as part of the program. This could be a great opportunity for those looking to make their environment healthier and reduce tobacco use. There are no specific exclusion criteria, so if you meet the inclusion requirements, you may be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (aged \>18 years) MSK patients as per the EHR
- • Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- • Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- • Must be English-speaking in the EHR
- • Must be reachable by phone as per self-report
- • Must have Wi-Fi available at home as per self-report
- Exclusion Criteria:
- • Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Montvale, New Jersey, United States
Uniondale, New York, United States
Harrison, New York, United States
Basking Ridge, New Jersey, United States
Middletown, New Jersey, United States
Commack, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Jamie Ostroff, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported